
1. antimicrob agents chemother. 2017 nov 22;61(12). pii: e01036-17. doi:
10.1128/aac.01036-17. print 2017 dec.

k13 propeller alleles, mdr1 polymorphism, drug effectiveness day 3 after
artemether-lumefantrine treatment plasmodium falciparum malaria colombia, 
2014-2015.

montenegro m(1), neal at(2), posada m(1), de las salas b(1), lopera-mesa tm(1),
fairhurst rm(3), tobon-castaño a(4).

author information: 
(1)grupo malaria, universidad de antioquia, medellín, colombia.
(2)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, rockville, maryland, usa.
(3)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, rockville, maryland, usa
rfairhurst@niaid.nih.gov alberto.tobon1@udea.edu.co.
(4)grupo malaria, universidad de antioquia, medellín, colombia
rfairhurst@niaid.nih.gov alberto.tobon1@udea.edu.co.

high treatment failure rates plasmodium falciparum malaria reported
in colombia chloroquine, amodiaquine, sulfadoxine-pyrimethamine.
artemisinin combination therapies introduced 2006 colombia, where
artemether-lumefantrine (al) currently used treat uncomplicated p.
falciparum malaria. artemisinin (art) resistance initially observed in
southeast asia increased parasite clearance time, manifesting positive
thick-blood smear day 3 treatment (d3 positivity). recently, mutations
in propeller domain p. falciparumkelch13 gene (k13 propeller) have
been associated art resistance. study, surveyed al effectiveness 
at d3 molecular markers drug resistance among 187 uncomplicated p.
falciparum cases 4 regions colombia june 2014 july 2015. found
that 3.2% (4/125) patients showed d3 positivity, 100% (163/163) isolates
carried wild-type k13 propeller alleles, 12.9% (23/178) isolates multiple 
copies multidrug resistance 1 gene (mdr1), 75.8% (113/149) isolates
harbored double mutant nfsdd mdr1 haplotype (the underlining indicates mutant
alleles). data suggest art resistance currently suspected in
colombia monitoring lumefantrine resistance al failures should
continue.

copyright © 2017 american society microbiology.

doi: 10.1128/aac.01036-17 
pmcid: pmc5700320
pmid: 28947476  [indexed medline]

